Form 4: Co-Diagnostics Director Acquires Shares Through Vesting of Restricted Stock Units
SEC Form 4
Director Eugene Durenard acquired 48,333 shares of Co-Diagnostics stock through the vesting of restricted stock units.
Summary
- Eugene Durenard, a director at Co-Diagnostics, Inc., acquired 48,333 shares of common stock on November 23, 2024.
- The acquisition resulted from the vesting of restricted stock units (RSUs) previously granted to Mr. Durenard.
- These RSUs are part of the company's 2015 Long Term Incentive Plan.
- The vested RSUs were awarded in multiple grants on July 7, 2022, January 17, 2023, June 12, 2023 and April 26, 2024.
- The RSUs vest in six equal installments every six months from the commencement date of each grant.
- Following the transaction, Mr. Durenard directly owns 163,333 shares of Co-Diagnostics common stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to executive compensation, which is generally viewed neutrally to positively by investors. The vesting of shares is a positive sign of alignment of interests.
Positives
- The vesting of restricted stock units aligns the director's interests with those of the shareholders.
- The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.
Industry Context
This is a routine transaction related to executive compensation and is common in publicly traded companies.
Comparison to Industry Standards
- The use of restricted stock units as part of executive compensation is a standard practice in the biotechnology and diagnostics industry.
- Many companies in the sector use similar vesting schedules to incentivize long-term performance and retention of key personnel.
- Companies such as Exact Sciences, Bio-Rad Laboratories, and QuidelOrtho also utilize stock-based compensation plans.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 2022-07-07 | Date of initial grant of 70,000 restricted stock units to the reporting person. |
| 2022-11-23 | First vesting date of the 2022-07-07 grant. |
| 2023-01-17 | Date of grant of 40,000 restricted stock units to the reporting person. |
| 2023-05-23 | First vesting date of the 2023-01-17 grant. |
| 2023-06-12 | Date of grant of 70,000 restricted stock units to the reporting person. |
| 2023-11-23 | First vesting date of the 2023-06-12 grant. |
| 2024-04-26 | Date of grant of 110,000 restricted stock units to the reporting person. |
| 2024-11-23 | Date of the reported transaction where 48,333 shares vested. |
| 2024-11-25 | Date of signature of the form. |
Keywords
Co-Diagnostics, Director, Stock Acquisition, Restricted Stock Units, Vesting, Incentive Plan, CODX
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.